# Sri Lanka Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Sri Lanka HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Sri Lanka (LKA)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $3.5M
- Products: 22
- Buyer markets: 28
- Average CAGR: +6.2%
- Global sector size: $426.7B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $301.0B | $546.5K | $113.7B | +11.1% | 20 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $29.3B | $382.9K | $20.1B | +16.7% | 11 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $10.4B | $168.9 | $10.8B | -21.8% | 3 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $2.1K | $10.7B | -2.1% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $2.5M | $8.0B | +25.8% | 4 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $8.2B | $1.2K | $6.1B | -11.3% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $8.2K | $4.6B | +9.9% | 3 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $7.0B | $6.3K | $3.6B | +12.4% | 2 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $5.5B | $395.4 | $3.2B | +33.7% | 1 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $8.0B | $18.6 | $2.9B | -5.4% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $6.9K | $2.2B | +10.9% | 2 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $2.2B | $361.0 | $1.8B | -2.8% | 1 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.4B | $51.3 | $1.7B | -4.4% | 1 | +0.0% |
| HS 284690 - Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $107.7 | $1.5B | +3.7% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $111.2 | $1.4B | -3.2% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $0.7 | $1.1B | -29.2% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $1.3 | $1.0B | +5.6% | 1 | +0.0% |
| HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.0B | $7.8K | $1.0B | -0.4% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $669.2M | $1.9K | $1.0B | +1.8% | 1 | +0.0% |
| HS 320611 - Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $1.1B | $2.2K | $997.2M | -10.0% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $25.0K | $990.0M | +4.9% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $895.5M | $0.5 | $959.0M | -57.3% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $38.1B calculated opportunity across 8 products.
- Switzerland, Liechtenstein (CHE): $33.9B calculated opportunity across 3 products.
- Belgium (BEL): $16.1B calculated opportunity across 3 products.
- China (CHN): $14.2B calculated opportunity across 5 products.
- United Kingdom (GBR): $10.8B calculated opportunity across 5 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- Germany (DEU): $9.7B calculated opportunity across 5 products.
- Canada (CAN): $7.5B calculated opportunity across 4 products.
- Mexico (MEX): $7.3B calculated opportunity across 3 products.
- France (FRA): $6.6B calculated opportunity across 4 products.
- Netherlands (NLD): $5.3B calculated opportunity across 1 products.
- Spain (ESP): $5.2B calculated opportunity across 1 products.

## Growth stars

- HS 300212: +33.7% average CAGR, $3.2B calculated opportunity.
- HS 330499: +25.8% average CAGR, $8.0B calculated opportunity.
- HS 382499: +16.7% average CAGR, $20.1B calculated opportunity.
- HS 330300: +12.4% average CAGR, $3.6B calculated opportunity.
- HS 300490: +11.1% average CAGR, $113.7B calculated opportunity.
- HS 300390: +10.9% average CAGR, $2.2B calculated opportunity.
- HS 382200: +9.9% average CAGR, $4.6B calculated opportunity.
- HS 300290: +5.6% average CAGR, $1.0B calculated opportunity.
- HS 294190: +4.9% average CAGR, $990.0M calculated opportunity.
- HS 284690: +3.7% average CAGR, $1.5B calculated opportunity.

## Diversification opportunities

- HS 300490: 20 buyer markets, $113.7B calculated opportunity.
- HS 382499: 11 buyer markets, $20.1B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 300439: 4 buyer markets, $6.1B calculated opportunity.
- HS 300220: 3 buyer markets, $10.8B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 382200: 3 buyer markets, $4.6B calculated opportunity.
- HS 330300: 2 buyer markets, $3.6B calculated opportunity.
- HS 300390: 2 buyer markets, $2.2B calculated opportunity.
- HS 300212: 1 buyer markets, $3.2B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.